Abstract

805P Tumor-informed ctDNA detection as a predictive marker for postoperative residual disease in epithelial ovarian cancer: A feasibility study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
#898 Tumor-informed CtDNA detection as a marker for postoperative residual disease in epithelial ovarian cancer – results of a feasibility study
Magdalena Postl ... Christoph Grimm
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 33
Magdalena Postl, et. al.Magdalena Postl ... Christoph Grimm
01 Sep 2023
Tumor-informed ctDNA as an objective marker for postoperative residual disease in epithelial ovarian cancer.
Valentina Paspalj ... Yilun Chen
-
Valentina Paspalj, et. al.Valentina Paspalj ... Yilun Chen
01 Jun 2024
Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review
Eric R Craig ... Rebecca C Arend
Gynecologic oncology | VOL. 143
Eric R Craig, et. al.Eric R Craig ... Rebecca C Arend
15 Oct 2016
Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium—OVCAD
Radoslav Chekerov ... Toon Van Gorp
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 23
Radoslav Chekerov, et. al.Radoslav Chekerov ... Toon Van Gorp
01 Feb 2013
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first-line and at relapse of chronic lymphocytic leukaemia
B Eichhorst ... C Buske
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
B Eichhorst, et. al.B Eichhorst ... C Buske
01 Jul 2024
Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer
M Cecchini ... R Sundar
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
M Cecchini, et. al.M Cecchini ... R Sundar
01 Jul 2024
Table of Contents
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
View more papers